Paul Tudor Jones’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
20,019
+15,057
+303% +$913K ﹤0.01% 2205
2026
Q1
$275K Sell
4,962
-12,343
-71% -$664K ﹤0.01% 3191
2025
Q4
$839K Buy
17,305
+3,436
+25% +$134K ﹤0.01% 2395
2025
Q3
$425K Buy
13,869
+4,450
+47% +$102K ﹤0.01% 2782
2025
Q2
$209K Sell
9,419
-775
-8% -$16.2K ﹤0.01% 3072
2025
Q1
$190K Sell
10,194
-168
-2% -$2.8K ﹤0.01% 2878
2024
Q4
$137K Buy
10,362
+382
+4% +$9.25K ﹤0.01% 2888
2024
Q3
$334K Buy
+9,980
New +$341K ﹤0.01% 2262
2024
Q1
Sell
-9,939
Closed -$213K 2184
2023
Q4
$213K Buy
+9,939
New +$171K ﹤0.01% 2181
2023
Q3
Sell
-10,307
Closed -$210K 2253
2023
Q2
$210K Sell
10,307
-4,877
-32% -$98.9K ﹤0.01% 2207
2023
Q1
$330K Buy
+15,184
New +$369K 0.01% 1859
2022
Q1
Sell
-6,140
Closed -$213K 1971
2021
Q4
$213K Buy
+6,140
New +$195K ﹤0.01% 2114
2021
Q3
Sell
-10,902
Closed -$283K 2423
2021
Q2
$283K Buy
+10,902
New +$261K 0.01% 1366
2020
Q1
Sell
-11,275
Closed -$183K 1036
2019
Q4
$183K Buy
11,275
+1,315
+13% +$31.1K 0.01% 1002
2019
Q3
$349K Buy
+9,960
New +$474K 0.01% 813

Other funds holding ANAB

Paul Tudor Jones's ANAB Position: Q2 2026 in Review

Paul Tudor Jones increased its AnaptysBio (ANAB) stake by 303% in Q2 2026, buying an estimated $913K and bringing the position to 20,019 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

Paul Tudor Jones first reported a position in ANAB in Q3 2019 and has held it in 15 quarters since. 211 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Paul Tudor Jones held 20,019 shares of AnaptysBio worth $1.35M as of Q2 2026.
  • Paul Tudor Jones bought 15,057 AnaptysBio shares in Q2 2026, an estimated $913K.
  • AnaptysBio made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2205 holding.
  • Paul Tudor Jones first reported a position in AnaptysBio in Q3 2019 and has held it in 15 quarters since.
  • 211 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.